Susan is Managing Director and Country President for Pfizer in the UK, leading the organisation’s work to deliver breakthroughs that change patients’ lives across the breadth of Pfizer’s innovative medicines and vaccines portfolio.
She is also President-elect of the ABPI (The Association of the British Pharmaceutical Industry), the industry body which exists to make the UK the best place in the world to research, develop and use new medicines and vaccines. Susan will formally take up this role following the ABPI’s Annual General Meeting (AGM) on 24th May, having previously served as the ABPI’s Vice President and co-chair of the ABPI’s Vaccine Group.
Prior to being appointed Pfizer’s UK Country President, Susan led the company’s UK Vaccines business unit during the COVID-19 pandemic, and before that the UK Hospital business unit and Essential Health division.
Susan has been at Pfizer for two decades, with experience across multiple global markets including in the US, Asia, and Europe, before moving to the UK in 2015.
14-Jun-2023In conversation with...The NHS at 75: how can we learn from international successes to improve the UK health system?